TRACON Pharmaceuticals, Inc. (TCON)
Company Info
Highlights
$109.73K
$5.93
0.01
$155.00K
$151.00K
-$6.12M
$0.02 - $14.75
$6.00
6.26%
0.95
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in TRACON Pharmaceuticals, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
TRACON Pharmaceuticals, Inc. had a return of 0.00% year-to-date (YTD) and -99.13% in the last 12 months. Over the past 10 years, TRACON Pharmaceuticals, Inc. had an annualized return of -66.97%, while the S&P 500 had an annualized return of 11.31%, indicating that TRACON Pharmaceuticals, Inc. did not perform as well as the benchmark.
TCON
0.00%
0.00%
-64.22%
-99.13%
-78.99%
-66.97%
^GSPC (Benchmark)
4.46%
2.46%
9.31%
23.49%
13.03%
11.31%
Monthly Returns
The table below presents the monthly returns of TCON, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 0.00% | 0.00% | |||||||||||
| 2024 | 8.22% | -4.49% | 137.46% | -79.87% | -26.01% | 25.00% | -94.38% | 0.11% | 16.67% | -47.62% | -20.91% | -25.98% | -99.08% |
| 2023 | 12.75% | -8.33% | 22.73% | -58.25% | -26.87% | -49.57% | 3.40% | -12.26% | -32.58% | -0.22% | 15.15% | -14.38% | -88.25% |
| 2022 | -6.50% | -2.32% | 3.95% | -23.57% | -14.43% | 16.28% | -11.50% | 11.86% | -15.66% | -5.39% | -4.75% | -1.00% | -46.21% |
| 2021 | -21.88% | 2.30% | -11.98% | -8.99% | -19.49% | 7.63% | -42.22% | -0.27% | 3.48% | -4.39% | -29.73% | 6.54% | -76.32% |
| 2020 | 71.79% | -24.38% | -44.08% | 13.53% | 19.17% | -14.78% | -15.82% | 14.55% | 173.54% | -10.25% | 116.38% | 16.53% | 400.00% |
| 2019 | 34.92% | 31.76% | 22.32% | -51.68% | -2.31% | 5.15% | -35.29% | 25.00% | -18.73% | -11.95% | -8.54% | -35.00% | -62.86% |
| 2018 | -13.43% | -23.28% | 3.37% | 8.70% | 6.00% | 1.89% | -9.26% | -14.29% | -2.38% | -31.71% | -2.86% | -53.68% | -81.19% |
| 2017 | -2.04% | -18.75% | -3.85% | -8.00% | -21.74% | -11.11% | -2.08% | 6.38% | 26.00% | -9.52% | -5.26% | 24.07% | -31.63% |
| 2016 | -17.32% | -13.09% | 5.27% | 3.58% | -7.73% | -34.43% | 16.44% | 22.35% | 6.89% | -16.04% | 2.68% | -14.78% | -46.97% |
| 2015 | 42.87% | 4.54% | -22.29% | 4.12% | -0.26% | 20.21% | -22.98% | -6.86% | 7.47% | 13.14% | -22.22% | -1.70% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of TCON is 27, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for TRACON Pharmaceuticals, Inc. (TCON) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the TRACON Pharmaceuticals, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the TRACON Pharmaceuticals, Inc. was 100.00%, occurring on Nov 26, 2024. The portfolio has not yet recovered.
The current TRACON Pharmaceuticals, Inc. drawdown is 100.00%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -100% | Mar 4, 2015 | 2451 | Nov 26, 2024 | — | — | — |
| -7.19% | Feb 27, 2015 | 1 | Feb 27, 2015 | 1 | Mar 2, 2015 | 2 |
| -4.42% | Feb 4, 2015 | 5 | Feb 10, 2015 | 2 | Feb 12, 2015 | 7 |
| -2.53% | Feb 13, 2015 | 2 | Feb 17, 2015 | 1 | Feb 18, 2015 | 3 |
| -2.25% | Feb 19, 2015 | 1 | Feb 19, 2015 | 3 | Feb 24, 2015 | 4 |
Volatility
Volatility Chart
The current TRACON Pharmaceuticals, Inc. volatility is 0.00%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of TRACON Pharmaceuticals, Inc. compared to its peers in the Biotechnology industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for TCON in comparison to other companies of the Biotechnology industry. Currently, TCON has a PE value of 0.0. This PE value is considered to be low compared to the rest of the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for TCON in comparison to other companies of the Biotechnology industry. Currently, TCON has a PEG value of 0.0. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for TRACON Pharmaceuticals, Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |